- Home
- MREO vs POET Comparison
MREO vs POET Comparison
Compare MREO & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- POET
- Stock Information
- Founded
- MREO 2015
- POET 1972
- Country
- MREO United Kingdom
- POET Canada
- Employees
- MREO N/A
- POET N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- POET Semiconductors
- Sector
- MREO Health Care
- POET Technology
- Exchange
- MREO Nasdaq
- POET Nasdaq
- Market Cap
- MREO 438.8M
- POET 450.6M
- IPO Year
- MREO N/A
- POET N/A
- Fundamental
- Price
- MREO $1.76
- POET $6.23
- Analyst Decision
- MREO Strong Buy
- POET Strong Buy
- Analyst Count
- MREO 5
- POET 2
- Target Price
- MREO $7.20
- POET $6.25
- AVG Volume (30 Days)
- MREO 4.4M
- POET 3.4M
- Earning Date
- MREO 08-12-2025
- POET 08-13-2025
- Dividend Yield
- MREO N/A
- POET N/A
- EPS Growth
- MREO N/A
- POET N/A
- EPS
- MREO N/A
- POET N/A
- Revenue
- MREO N/A
- POET $199,477.00
- Revenue This Year
- MREO N/A
- POET $8,377.56
- Revenue Next Year
- MREO $51.92
- POET $1,061.73
- P/E Ratio
- MREO N/A
- POET N/A
- Revenue Growth
- MREO N/A
- POET N/A
- 52 Week Low
- MREO $1.57
- POET $2.27
- 52 Week High
- MREO $5.02
- POET $7.79
- Technical
- Relative Strength Index (RSI)
- MREO 35.35
- POET 54.73
- Support Level
- MREO $1.65
- POET $5.94
- Resistance Level
- MREO $1.89
- POET $6.95
- Average True Range (ATR)
- MREO 0.15
- POET 0.59
- MACD
- MREO -0.03
- POET -0.09
- Stochastic Oscillator
- MREO 12.84
- POET 45.02
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.